Civitas Therapeutics was a biopharmaceutical company focused on developing and commercializing transformative therapeutics using its proprietary ARCUS technology. The company specialized in pulmonary delivery therapies and was acquired by Acorda Therapeutics in 2014.
Focus Areas
Notable Investments
